Literature DB >> 4892617

Double-blind crossover comparison of bc-105, methysergide and placebo in the prophylaxis of migraine headache.

R E Ryan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4892617     DOI： 10.1111/j.1526-4610.1968.hed0803118.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  7 in total

Review 1.  5-Hydroxytryptamine and the pathophysiology of migraine.

Authors:  P P Humphrey
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

2.  The central action of pizotifen.

Authors:  E Przegaliński; L Baran; W Palider; J Siwanowicz
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

Review 3.  Practical approaches to migraine management.

Authors:  Seymour Diamond; Richard Wenzel
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Comparative trial of serotonin antagonists in the management of migraine.

Authors:  J W Lance; M Anthony; B Somerville
Journal:  Br Med J       Date:  1970-05-09

Review 5.  Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

6.  A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.

Authors:  Jeffrey L Jackson; Elizabeth Cogbill; Rafael Santana-Davila; Christina Eldredge; William Collier; Andrew Gradall; Neha Sehgal; Jessica Kuester
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

7.  Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors:  Michel Dib
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.